• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

台湾地区COVID-19疫苗接种后的眼部炎症表现:病例系列

Ocular inflammatory manifestations following COVID-19 vaccinations in Taiwan: A case series.

作者信息

Wang Ling-Uei, Chen Fang-Ting, Wang Jia-Kang, Huang Tzu-Lun, Chang Pei-Yao, Chen Yun-Ju, Hsu Yung-Ray

机构信息

Department of Ophthalmology, Far Eastern Memorial Hospital, New Taipei City, Taiwan.

Department of Ophthalmology, National Taiwan University Hospital, Taipei, Taiwan.

出版信息

Taiwan J Ophthalmol. 2022 Aug 1;12(4):465-471. doi: 10.4103/2211-5056.353129. eCollection 2022 Oct-Dec.

DOI:10.4103/2211-5056.353129
PMID:36660122
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9843569/
Abstract

As a continuing demand for booster shots against SARS-CoV-2, ocular adverse events following the coronavirus disease-2019 (COVID-19) vaccines can cause significant visual impairment, and they warrant a high awareness and detailed documentation of possible ocular inflammatory manifestations. We present a case series of 11 patients presenting with ocular manifestations relevant to vaccine-associated autoimmune response within 6 weeks after the vaccination of the Oxford-AstraZeneca, the Moderna, and Pfizer-BioNTech vaccines at the main tertiary referral center in the most populated and most vaccinated city in Taiwan. Their diagnosis included five acute anterior uveitis, two multiple evanescent white dot syndrome, one probable Vogt-Koyanagi-Harada disease, one anterior scleritis, one relapsed idiopathic panuveitis, and one autoantibody-related central retinal artery occlusion. This report presented a broad spectrum of the ocular inflammatory events following the vaccination of COVID-19. Early recognition of the clinical manifestations mentioned herein with prompt management is crucial in recovering the patients' vision.

摘要

由于对严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)加强针的持续需求,2019冠状病毒病(COVID-19)疫苗接种后的眼部不良事件可导致严重视力损害,因此需要高度警惕并详细记录可能出现的眼部炎症表现。我们报告了一系列病例,共11例患者,在台湾人口最多、疫苗接种率最高的城市的主要三级转诊中心,接种牛津-阿斯利康、莫德纳和辉瑞-生物科技疫苗后6周内出现了与疫苗相关的自身免疫反应相关的眼部表现。他们的诊断包括5例急性前葡萄膜炎、2例多发性一过性白点综合征、1例可能的伏格特-小柳-原田病、1例前巩膜炎、1例复发性特发性全葡萄膜炎和1例自身抗体相关的视网膜中央动脉阻塞。本报告展示了COVID-19疫苗接种后广泛的眼部炎症事件。早期识别本文所述的临床表现并及时处理对于恢复患者视力至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d44/9843569/7a9a939956fd/TJO-12-465-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d44/9843569/76741d698b49/TJO-12-465-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d44/9843569/bad7b4e47b13/TJO-12-465-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d44/9843569/7a9a939956fd/TJO-12-465-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d44/9843569/76741d698b49/TJO-12-465-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d44/9843569/bad7b4e47b13/TJO-12-465-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d44/9843569/7a9a939956fd/TJO-12-465-g003.jpg

相似文献

1
Ocular inflammatory manifestations following COVID-19 vaccinations in Taiwan: A case series.台湾地区COVID-19疫苗接种后的眼部炎症表现:病例系列
Taiwan J Ophthalmol. 2022 Aug 1;12(4):465-471. doi: 10.4103/2211-5056.353129. eCollection 2022 Oct-Dec.
2
Uveitis and Other Ocular Complications Following COVID-19 Vaccination.新冠疫苗接种后的葡萄膜炎及其他眼部并发症
J Clin Med. 2021 Dec 19;10(24):5960. doi: 10.3390/jcm10245960.
3
Posterior ocular manifestations following BNT162b2 mRNA COVID-19 vaccine: a case series.BNT162b2 mRNA COVID-19 疫苗接种后的眼部后效:病例系列。
Int Ophthalmol. 2023 May;43(5):1677-1686. doi: 10.1007/s10792-022-02565-2. Epub 2022 Oct 31.
4
A multicenter study of ocular inflammation after COVID-19 vaccination.一项关于 COVID-19 疫苗接种后眼部炎症的多中心研究。
Jpn J Ophthalmol. 2023 Jan;67(1):14-21. doi: 10.1007/s10384-022-00962-9. Epub 2022 Nov 22.
5
COVID Vaccine-Associated Uveitis.COVID 疫苗相关性虹膜炎。
Ocul Immunol Inflamm. 2023 Aug;31(6):1198-1205. doi: 10.1080/09273948.2023.2200858. Epub 2023 May 5.
6
Vision-Threatening Ocular Adverse Events after Vaccination against Coronavirus Disease 2019.2019年冠状病毒病疫苗接种后的视力威胁性眼部不良事件
J Clin Med. 2022 Jun 9;11(12):3318. doi: 10.3390/jcm11123318.
7
Ocular manifestations following COVID-19 vaccination.新型冠状病毒肺炎疫苗接种后的眼部表现。
J Ophthalmic Inflamm Infect. 2023 Sep 23;13(1):44. doi: 10.1186/s12348-023-00358-x.
8
Ocular Adverse Events After COVID-19 Vaccination.接种 COVID-19 疫苗后的眼部不良反应。
Ocul Immunol Inflamm. 2021 Aug 18;29(6):1216-1224. doi: 10.1080/09273948.2021.1976221. Epub 2021 Sep 24.
9
Case report: Bilateral panuveitis resembling Vogt-Koyanagi-Harada disease after second dose of BNT162b2 mRNA COVID-19 vaccine.病例报告:第二剂 BNT162b2 mRNA COVID-19 疫苗接种后双侧全葡萄膜炎,类似 Vogt-Koyanagi-Harada 病。
Front Immunol. 2022 Sep 29;13:967972. doi: 10.3389/fimmu.2022.967972. eCollection 2022.
10
Multiple Evanescent White Dot Syndrome following COVID-19 mRNA Vaccination in Two Patients.两例 COVID-19 mRNA 疫苗接种后多发性一过性白点综合征。
Ocul Immunol Inflamm. 2022 Jul;30(5):1240-1243. doi: 10.1080/09273948.2022.2032198. Epub 2022 Feb 24.

引用本文的文献

1
Manifestations of COVID-19 in the posterior eye segment - Up-to-date.新型冠状病毒肺炎在后段眼的表现——最新情况。
Oman J Ophthalmol. 2024 Jun 27;17(2):166-172. doi: 10.4103/ojo.ojo_212_22. eCollection 2024 May-Aug.
2
Comprehensive insights into COVID-19 vaccine-associated multiple evanescent white dot syndrome (MEWDS): A systematic analysis of reported cases.全面了解 COVID-19 疫苗相关多发性一过性白点综合征(MEWDS):对已报道病例的系统分析。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2350812. doi: 10.1080/21645515.2024.2350812. Epub 2024 May 16.
3
The characteristics of white dot syndromes following COVID-19 Vaccines: a systematic review.

本文引用的文献

1
Vogt-Koyanagi-Harada disease following influenza vaccination.流感疫苗接种后发生的葡萄膜大脑炎。
Am J Ophthalmol Case Rep. 2022 Apr 10;26:101516. doi: 10.1016/j.ajoc.2022.101516. eCollection 2022 Jun.
2
Natural history of PF4 antibodies in vaccine-induced immune thrombocytopenia and thrombosis.疫苗诱导免疫性血小板减少症和血栓形成中 PF4 抗体的自然史。
Blood. 2022 Apr 21;139(16):2553-2560. doi: 10.1182/blood.2021014684.
3
Vogt-Koyanagi-Harada Disease following Covid-19 Vaccine: A Case Report and Literature Overview.新冠疫苗接种后发生的伏格特-小柳-原田病:一例报告及文献综述
新冠疫苗接种后白点综合征的特征:一项系统综述。
Int Ophthalmol. 2024 Apr 23;44(1):189. doi: 10.1007/s10792-024-03119-4.
4
Vogt-Koyanagi-Harada Disease and COVID.伏格特-小柳-原田病与新冠病毒
J Clin Med. 2023 Sep 27;12(19):6242. doi: 10.3390/jcm12196242.
5
Correction.更正。
Hum Vaccin Immunother. 2023 Aug;19(2):2259160. doi: 10.1080/21645515.2023.2259160. Epub 2023 Sep 21.
6
Retinal vascular occlusion following SARS-CoV-2 vaccination: A VAERS database analysis.新型冠状病毒2型疫苗接种后视网膜血管阻塞:疫苗不良事件报告系统(VAERS)数据库分析
Ophthalmol Sci. 2023 Jun 20;4(1):100354. doi: 10.1016/j.xops.2023.100354.
7
Clinical features, diagnosis, and management of COVID-19 vaccine-associated Vogt-Koyanagi-Harada disease.COVID-19 疫苗相关 Vogt-Koyanagi-Harada 病的临床特征、诊断和治疗。
Hum Vaccin Immunother. 2023 Aug 1;19(2):2220630. doi: 10.1080/21645515.2023.2220630. Epub 2023 Jun 6.
8
Ocular Vascular Events following COVID-19 Vaccines: A Systematic Review.新冠疫苗接种后的眼部血管事件:一项系统综述
Vaccines (Basel). 2022 Dec 14;10(12):2143. doi: 10.3390/vaccines10122143.
Ocul Immunol Inflamm. 2022 Jul;30(5):1292-1295. doi: 10.1080/09273948.2022.2028291. Epub 2022 Feb 3.
4
Ocular Manifestations after Receiving COVID-19 Vaccine: A Systematic Review.接种新冠疫苗后的眼部表现:一项系统评价
Vaccines (Basel). 2021 Nov 27;9(12):1404. doi: 10.3390/vaccines9121404.
5
Retinal Vascular Events after mRNA and Adenoviral-Vectored COVID-19 Vaccines-A Case Series.mRNA和腺病毒载体新冠疫苗接种后的视网膜血管事件——病例系列
Vaccines (Basel). 2021 Nov 17;9(11):1349. doi: 10.3390/vaccines9111349.
6
Vogt-Koyanagi-Harada Disease Associated with COVID-19 mRNA Vaccine.与 COVID-19 mRNA 疫苗相关的 Vogt-Koyanagi-Harada 病。
Ocul Immunol Inflamm. 2021 Aug 18;29(6):1212-1215. doi: 10.1080/09273948.2021.1974492. Epub 2021 Sep 10.
7
Association of Ocular Adverse Events With Inactivated COVID-19 Vaccination in Patients in Abu Dhabi.在阿布扎比,眼部不良事件与 COVID-19 灭活疫苗接种的关联。
JAMA Ophthalmol. 2021 Oct 1;139(10):1131-1135. doi: 10.1001/jamaophthalmol.2021.3477.
8
Vogt-Koyanagi-Harada Syndrome following COVID-19 and ChAdOx1 nCoV-19 (AZD1222) vaccine.新冠病毒感染和ChAdOx1 nCoV-19(AZD1222)疫苗接种后发生的伏格特-小柳-原田综合征
Int J Retina Vitreous. 2021 Aug 30;7(1):49. doi: 10.1186/s40942-021-00319-3.
9
Central retinal vein occlusion occurring immediately after 2nd dose of mRNA SARS-CoV-2 vaccine.在第二剂mRNA新冠疫苗接种后立即发生的视网膜中央静脉阻塞。
Int Ophthalmol. 2021 Dec;41(12):3889-3892. doi: 10.1007/s10792-021-01971-2. Epub 2021 Aug 23.
10
Hyperbaric Oxygen Therapy for Central Retinal Artery Occlusion: Patient Selection and Perspectives.高压氧治疗视网膜中央动脉阻塞:患者选择与展望。
Clin Ophthalmol. 2021 Aug 13;15:3443-3457. doi: 10.2147/OPTH.S224192. eCollection 2021.